NM_031885.5(BBS2):c.1139A>G (p.Asn380Ser) AND Bardet-Biedl syndrome 2

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Apr 16, 2020
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001831130.1

Allele description [Variation Report for NM_031885.5(BBS2):c.1139A>G (p.Asn380Ser)]

NM_031885.5(BBS2):c.1139A>G (p.Asn380Ser)

Gene:

BBS2:Bardet-Biedl syndrome 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16q13

Genomic location:

Preferred name:

NM_031885.5(BBS2):c.1139A>G (p.Asn380Ser)

HGVS:

NC_000016.10:g.56501439T>C
NG_009312.2:g.23586A>G
NM_001377456.1:c.1139A>G
NM_031885.5:c.1139A>GMANE SELECT
NP_001364385.1:p.Asn380Ser
NP_114091.4:p.Asn380Ser
NC_000016.9:g.56535351T>C
NG_009312.1:g.23845A>G
NR_165293.1:n.1301A>G
NR_165294.1:n.1301A>G
NR_165295.1:n.1301A>G
NR_165296.1:n.1301A>G
NR_165297.1:n.1301A>G

Protein change:

N380S

Links:

dbSNP: rs773720173

Molecular consequence:

NM_001377456.1:c.1139A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_031885.5:c.1139A>G - missense variant - [Sequence Ontology: SO:0001583]
NR_165293.1:n.1301A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_165294.1:n.1301A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_165295.1:n.1301A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_165296.1:n.1301A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_165297.1:n.1301A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Bardet-Biedl syndrome 2 (BBS2)
Identifiers:: MONDO: MONDO:0014432; MedGen: C2936863; Orphanet: 110; OMIM: 615981

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002089281	Natera, Inc.	no assertion criteria provided	Uncertain significance (Apr 16, 2020)	germline	clinical testing

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002089281

Natera, Inc.

no assertion criteria provided

Uncertain significance
(Apr 16, 2020)

germline

clinical testing

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Natera, Inc., SCV002089281.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine